Implementing genomic medicine in the clinic: The future is here

Teri A. Manolio, Rex L. Chisholm, Brad Ozenberger, Dan M. Roden, Marc S. Williams, Richard Wilson, David Bick, Erwin P. Bottinger, Murray H. Brilliant, Charis Eng, Kelly A. Frazer, Bruce Korf, David H. Ledbetter, James R. Lupski, Clay Marsh, David Mrazek, Michael F. Murray, Peter H. O'Donnell, Daniel J. Rader, Mary V. RellingAlan R. Shuldiner, David Valle, Richard M Weinshilboum, Eric D. Green, Geoffrey S. Ginsburg

Research output: Contribution to journalArticle

302 Citations (Scopus)

Abstract

Although the potential for genomics to contribute to clinical care has long been anticipated, the pace of defining the risks and benefits of incorporating genomic findings into medical practice has been relatively slow. Several institutions have recently begun genomic medicine programs, encountering many of the same obstacles and developing the same solutions, often independently. Recognizing that successful early experiences can inform subsequent efforts, the National Human Genome Research Institute brought together a number of these groups to describe their ongoing projects and challenges, identify common infrastructure and research needs, and outline an implementation framework for investigating and introducing similar programs elsewhere. Chief among the challenges were limited evidence and consensus on which genomic variants were medically relevant; lack of reimbursement for genomically driven interventions; and burden to patients and clinicians of assaying, reporting, intervening, and following up genomic findings. Key infrastructure needs included an openly accessible knowledge base capturing sequence variants and their phenotypic associations and a framework for defining and cataloging clinically actionable variants. Multiple institutions are actively engaged in using genomic information in clinical care. Much of this work is being done in isolation and would benefit from more structured collaboration and sharing of best practices.

Original languageEnglish (US)
Pages (from-to)258-267
Number of pages10
JournalGenetics in Medicine
Volume15
Issue number4
DOIs
StatePublished - Apr 2013

Fingerprint

National Human Genome Research Institute (U.S.)
Cataloging
Knowledge Bases
Genomics
Practice Guidelines
Medicine
Research

Keywords

  • medical genomics
  • practice standards

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Manolio, T. A., Chisholm, R. L., Ozenberger, B., Roden, D. M., Williams, M. S., Wilson, R., ... Ginsburg, G. S. (2013). Implementing genomic medicine in the clinic: The future is here. Genetics in Medicine, 15(4), 258-267. https://doi.org/10.1038/gim.2012.157

Implementing genomic medicine in the clinic : The future is here. / Manolio, Teri A.; Chisholm, Rex L.; Ozenberger, Brad; Roden, Dan M.; Williams, Marc S.; Wilson, Richard; Bick, David; Bottinger, Erwin P.; Brilliant, Murray H.; Eng, Charis; Frazer, Kelly A.; Korf, Bruce; Ledbetter, David H.; Lupski, James R.; Marsh, Clay; Mrazek, David; Murray, Michael F.; O'Donnell, Peter H.; Rader, Daniel J.; Relling, Mary V.; Shuldiner, Alan R.; Valle, David; Weinshilboum, Richard M; Green, Eric D.; Ginsburg, Geoffrey S.

In: Genetics in Medicine, Vol. 15, No. 4, 04.2013, p. 258-267.

Research output: Contribution to journalArticle

Manolio, TA, Chisholm, RL, Ozenberger, B, Roden, DM, Williams, MS, Wilson, R, Bick, D, Bottinger, EP, Brilliant, MH, Eng, C, Frazer, KA, Korf, B, Ledbetter, DH, Lupski, JR, Marsh, C, Mrazek, D, Murray, MF, O'Donnell, PH, Rader, DJ, Relling, MV, Shuldiner, AR, Valle, D, Weinshilboum, RM, Green, ED & Ginsburg, GS 2013, 'Implementing genomic medicine in the clinic: The future is here', Genetics in Medicine, vol. 15, no. 4, pp. 258-267. https://doi.org/10.1038/gim.2012.157
Manolio TA, Chisholm RL, Ozenberger B, Roden DM, Williams MS, Wilson R et al. Implementing genomic medicine in the clinic: The future is here. Genetics in Medicine. 2013 Apr;15(4):258-267. https://doi.org/10.1038/gim.2012.157
Manolio, Teri A. ; Chisholm, Rex L. ; Ozenberger, Brad ; Roden, Dan M. ; Williams, Marc S. ; Wilson, Richard ; Bick, David ; Bottinger, Erwin P. ; Brilliant, Murray H. ; Eng, Charis ; Frazer, Kelly A. ; Korf, Bruce ; Ledbetter, David H. ; Lupski, James R. ; Marsh, Clay ; Mrazek, David ; Murray, Michael F. ; O'Donnell, Peter H. ; Rader, Daniel J. ; Relling, Mary V. ; Shuldiner, Alan R. ; Valle, David ; Weinshilboum, Richard M ; Green, Eric D. ; Ginsburg, Geoffrey S. / Implementing genomic medicine in the clinic : The future is here. In: Genetics in Medicine. 2013 ; Vol. 15, No. 4. pp. 258-267.
@article{e8f5aa4f62d44baf8726c879613a9df1,
title = "Implementing genomic medicine in the clinic: The future is here",
abstract = "Although the potential for genomics to contribute to clinical care has long been anticipated, the pace of defining the risks and benefits of incorporating genomic findings into medical practice has been relatively slow. Several institutions have recently begun genomic medicine programs, encountering many of the same obstacles and developing the same solutions, often independently. Recognizing that successful early experiences can inform subsequent efforts, the National Human Genome Research Institute brought together a number of these groups to describe their ongoing projects and challenges, identify common infrastructure and research needs, and outline an implementation framework for investigating and introducing similar programs elsewhere. Chief among the challenges were limited evidence and consensus on which genomic variants were medically relevant; lack of reimbursement for genomically driven interventions; and burden to patients and clinicians of assaying, reporting, intervening, and following up genomic findings. Key infrastructure needs included an openly accessible knowledge base capturing sequence variants and their phenotypic associations and a framework for defining and cataloging clinically actionable variants. Multiple institutions are actively engaged in using genomic information in clinical care. Much of this work is being done in isolation and would benefit from more structured collaboration and sharing of best practices.",
keywords = "medical genomics, practice standards",
author = "Manolio, {Teri A.} and Chisholm, {Rex L.} and Brad Ozenberger and Roden, {Dan M.} and Williams, {Marc S.} and Richard Wilson and David Bick and Bottinger, {Erwin P.} and Brilliant, {Murray H.} and Charis Eng and Frazer, {Kelly A.} and Bruce Korf and Ledbetter, {David H.} and Lupski, {James R.} and Clay Marsh and David Mrazek and Murray, {Michael F.} and O'Donnell, {Peter H.} and Rader, {Daniel J.} and Relling, {Mary V.} and Shuldiner, {Alan R.} and David Valle and Weinshilboum, {Richard M} and Green, {Eric D.} and Ginsburg, {Geoffrey S.}",
year = "2013",
month = "4",
doi = "10.1038/gim.2012.157",
language = "English (US)",
volume = "15",
pages = "258--267",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Implementing genomic medicine in the clinic

T2 - The future is here

AU - Manolio, Teri A.

AU - Chisholm, Rex L.

AU - Ozenberger, Brad

AU - Roden, Dan M.

AU - Williams, Marc S.

AU - Wilson, Richard

AU - Bick, David

AU - Bottinger, Erwin P.

AU - Brilliant, Murray H.

AU - Eng, Charis

AU - Frazer, Kelly A.

AU - Korf, Bruce

AU - Ledbetter, David H.

AU - Lupski, James R.

AU - Marsh, Clay

AU - Mrazek, David

AU - Murray, Michael F.

AU - O'Donnell, Peter H.

AU - Rader, Daniel J.

AU - Relling, Mary V.

AU - Shuldiner, Alan R.

AU - Valle, David

AU - Weinshilboum, Richard M

AU - Green, Eric D.

AU - Ginsburg, Geoffrey S.

PY - 2013/4

Y1 - 2013/4

N2 - Although the potential for genomics to contribute to clinical care has long been anticipated, the pace of defining the risks and benefits of incorporating genomic findings into medical practice has been relatively slow. Several institutions have recently begun genomic medicine programs, encountering many of the same obstacles and developing the same solutions, often independently. Recognizing that successful early experiences can inform subsequent efforts, the National Human Genome Research Institute brought together a number of these groups to describe their ongoing projects and challenges, identify common infrastructure and research needs, and outline an implementation framework for investigating and introducing similar programs elsewhere. Chief among the challenges were limited evidence and consensus on which genomic variants were medically relevant; lack of reimbursement for genomically driven interventions; and burden to patients and clinicians of assaying, reporting, intervening, and following up genomic findings. Key infrastructure needs included an openly accessible knowledge base capturing sequence variants and their phenotypic associations and a framework for defining and cataloging clinically actionable variants. Multiple institutions are actively engaged in using genomic information in clinical care. Much of this work is being done in isolation and would benefit from more structured collaboration and sharing of best practices.

AB - Although the potential for genomics to contribute to clinical care has long been anticipated, the pace of defining the risks and benefits of incorporating genomic findings into medical practice has been relatively slow. Several institutions have recently begun genomic medicine programs, encountering many of the same obstacles and developing the same solutions, often independently. Recognizing that successful early experiences can inform subsequent efforts, the National Human Genome Research Institute brought together a number of these groups to describe their ongoing projects and challenges, identify common infrastructure and research needs, and outline an implementation framework for investigating and introducing similar programs elsewhere. Chief among the challenges were limited evidence and consensus on which genomic variants were medically relevant; lack of reimbursement for genomically driven interventions; and burden to patients and clinicians of assaying, reporting, intervening, and following up genomic findings. Key infrastructure needs included an openly accessible knowledge base capturing sequence variants and their phenotypic associations and a framework for defining and cataloging clinically actionable variants. Multiple institutions are actively engaged in using genomic information in clinical care. Much of this work is being done in isolation and would benefit from more structured collaboration and sharing of best practices.

KW - medical genomics

KW - practice standards

UR - http://www.scopus.com/inward/record.url?scp=84875939245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875939245&partnerID=8YFLogxK

U2 - 10.1038/gim.2012.157

DO - 10.1038/gim.2012.157

M3 - Article

C2 - 23306799

AN - SCOPUS:84875939245

VL - 15

SP - 258

EP - 267

JO - Genetics in Medicine

JF - Genetics in Medicine

SN - 1098-3600

IS - 4

ER -